Lifordi Immunotherapeutics
- Biotech or pharma, therapeutic R&D
Lifordi Immunotherapeutics is developing antibody drug conjugate (ADC) therapies for autoimmune and inflammatory disorders using a novel delivery platform that targets a specific, highly internalized cell surface membrane protein on immune cells.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}